Trubridge Earnings Call Highlights Profit, Pipeline Shift

Trubridge, Inc. ((TBRG)) has held its Q4 earnings call. Read on for the main highlights of the call.

Trubridge’s latest earnings call struck a cautiously upbeat tone as management highlighted stronger margins, improved cash generation, lower leverage and a healthier sales pipeline, while acknowledging modest revenue growth and lingering pressures in parts of the business. Executives framed the year as a turning point in operational discipline, even as they flagged near-term risks around retention, pipeline conversion and a still-ongoing strategic review.

10-K Filing, Controls and Accounting Cleanup

Trubridge completed its 10-K after uncovering noncash, out-of-period accounting adjustments during its first year-end audit with a new external auditor. Management stressed that reporting standards and financial controls have been strengthened, with remediation of material weaknesses underway following restatements tied to revenue timing, contract costs and capitalized software.

Revenue Growth Slow but Positive

Full-year 2025 revenue reached $346.8 million, representing a modest 1.4% increase versus the prior year and underscoring that top-line momentum remains limited. Executives acknowledged this slow growth pace, noting that future expansion will depend on converting a larger pipeline and sustaining operational gains rather than headline revenue acceleration today.

EBITDA Growth and Margin Expansion

Adjusted EBITDA climbed to $68.7 million, a 23% year-over-year increase that far outpaced revenue growth. The company expanded adjusted EBITDA margins by 350 basis points for the year and more than 650 basis points over two years, highlighting tighter cost control and operational efficiency as primary drivers of improved profitability.

Q4 Profitability at High End of Range

In the fourth quarter, adjusted EBITDA of $19.2 million landed at the high end of management’s guidance. Q4 adjusted EBITDA margin reached 22%, up 160 basis points from the same quarter last year, signaling that the profitability improvements seen in 2025 are becoming more consistent even amid soft revenue trends.

Improved Cash Generation and Liquidity

Cash flow from operations rose 19% to $37 million, while free cash flow increased by $5 million to $20 million, reflecting better earnings quality and capital discipline. The company ended the year with $24.9 million in cash, more than double the prior year’s $12.3 million, providing additional flexibility for investment and balance-sheet management.

Deleveraging and Extended Credit Capacity

Trubridge reduced net debt by roughly $19.5 million year-to-date, bringing it down to about $139.8 million and lowering net leverage to around 2.0 times, marking a fourth straight quarter below 2.5 times. The company also amended and extended its credit agreement for five years, securing access to a facility of up to $250 million and reinforcing its liquidity position.

Bookings Growth and Pipeline Momentum

Fourth-quarter bookings reached $19.8 million in total contract value, up $6 million year-over-year and $4 million sequentially, while full-year TCV bookings totaled $82.9 million with $70.9 million in ACV. Management highlighted that the overall sales pipeline is now at a nine-quarter high and has grown 53% since the beginning of the third quarter, setting the stage for future growth if conversion improves.

Shift Toward Higher-Quality Opportunities

The composition of the pipeline is tilting toward more durable and scalable revenue as recurring deals now account for over 70% of opportunities, compared with about 57% last summer. Larger hospital prospects are playing a bigger role, with opportunities involving more than 100 beds rising to 30% of the pipeline, and encoder-related opportunities growing 74%, suggesting a richer mix of potential contracts.

Global Delivery Expansion and Operational Execution

The company advanced its global delivery strategy by opening a new Global Capacity Center in Chennai and pushing ahead with a broader workforce transition. Management reported early progress in improving retention in its central business office operations, helped by a more structured transition model and tighter oversight, though some benefits are still expected to take time.

AI Strategy and Early Wins

Trubridge laid out a four-pillar AI strategy spanning financial health, patient care, customer service and internal development, with early pilots already yielding tangible benefits. These include reduced provider documentation time through ambient technology, an internal AI support bot that speeds and standardizes responses and an exclusive integration with a leading clinical documentation tool to deepen adoption.

Q4 Revenue Dip and Product Sunset Drag

Quarterly revenue came in at $87.2 million, down about 1% compared with the prior year, reflecting ongoing challenges on the top line. Within that, Patient Care revenue fell 6.6% to $31 million, with management noting that the planned sunset of the Centriq product shaved roughly $1 million from Q4 revenue and that results would have been about flat without this drag.

Retention Challenges from Global Transition

The transition to more offshore delivery created customer retention headwinds in the company’s central business office segment during 2024. While remediation steps and enhanced oversight are in place and early indicators are improving, leaders cautioned that attrition effects are still weighing on performance and some operational benefits from the new model remain several quarters away.

Accounting Adjustments and Reporting Delay

Management detailed that material noncash misstatements related to revenue timing, contract cost accounting and capitalized software required restating prior periods. These corrections delayed the 10-K filing and triggered an extensive remediation process, but executives emphasized that the issues did not affect cash and that control enhancements are a key focus going forward.

Pipeline Conversion and Booking Volatility

Despite the larger and higher-quality pipeline, Trubridge cautioned that the timing of deal signings remains difficult to predict, with seasonality and customer decision cycles adding noise. Leaders suggested the company may still be a quarter or two away from consistently strong bookings each period, underscoring some near-term uncertainty around revenue acceleration.

Patient Care Margin Compression

Patient Care gross margin slipped to 59% in the fourth quarter, a decline of 75 basis points compared with the prior year. Management linked the margin pressure primarily to shifts in revenue mix and timing in that segment, highlighting this as an area of focus for future optimization as new products and service models scale.

Guidance, Outlook and Strategic Review

Amid an ongoing strategic review, Trubridge withheld formal numeric guidance but outlined expectations for modest revenue growth in 2026 and about 200 basis points of further adjusted EBITDA margin improvement. Executives pointed to recent cash-flow gains, margin expansion, stronger bookings and a more recurring, larger-deal pipeline as supporting this outlook, while acknowledging that visibility remains somewhat constrained during the review process.

The call painted a picture of a company tightening its operations, repairing its balance sheet and investing in AI and global delivery while still wrestling with muted revenue growth and transition-related friction. For investors, Trubridge now looks like a more profitable and better-capitalized business, but the pace at which its enlarged pipeline converts into sustained top-line growth remains a key swing factor to watch.